However, more recent studies employing whole-genome sequencing (WGS) and immunohistochemistry (IHC) have revealed that RB1 deletions or overexpression of phosphorylated protein are present in at least 25% of PCa patients [52,83,98,99]. The gene discussed is RB1; the disease is posterior cortical atrophy.